Cargando…
SOX10 – A Novel Marker for the Differential Diagnosis of Breast Metaplastic Squamous Cell Carcinoma
INTRODUCTION: Differential diagnosis of metaplastic squamous cell carcinoma of breast (MSCCB) is difficult. In particular, in terms of metastatic MSCCB, because of the low speciality of traditional markers such as mammaglobin, gross cystic disease fluid protein-15 (GCDFP-15) and GATA binding protein...
Autores principales: | Qi, Jialin, Hu, Zhenmin, Xiao, Heng, Liu, Ruijie, Guo, Wei, Yang, Zhichun, Ma, Kewen, Su, Shitong, Tang, Ping, Zhou, Xunjian, Zhou, Jianhua, Wang, Kuansong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266319/ https://www.ncbi.nlm.nih.gov/pubmed/32547236 http://dx.doi.org/10.2147/CMAR.S250867 |
Ejemplares similares
-
Purified Vitexin Compound 1 Serves as a Promising Antineoplastic Agent in Ovarian Cancer
por: Ma, Kewen, et al.
Publicado: (2021) -
Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer
por: Cao, Yi, et al.
Publicado: (2023) -
Hypercalcemia in Metaplastic Squamous Cell Carcinoma of the Breast
por: Hardy, Brendan M., et al.
Publicado: (2019) -
Diagnosis of metaplastic synovial cysts in clinical dermatology
por: Vora, Paayal S., et al.
Publicado: (2022) -
Treatment strategies for clear cell renal cell carcinoma: Past, present and future
por: Yang, Junwei, et al.
Publicado: (2023)